The mechanistic insight of a specific interaction between 15d-Prostaglandin-J2 and eIF4A suggests an evolutionary conserved role across species by Yun, S.J. et al.
RESEARCH ARTICLE
The mechanistic insight of a specific interaction between
15d-Prostaglandin-J2 and eIF4A suggests an evolutionary
conserved role across species
So Jeong Yun2,*, Hyunjoon Kim1, Seung-Hyun Jung3, Joon Hyun Kim1, Jeong Eun Ryu1, N. Jiten Singh4,
Jouhyun Jeon5, Jin-Kwan Han1, Cheol-Hee Kim3, Sanguk Kim5,6, Sung Key Jang1 and Woo Jae Kim7,*,‡
ABSTRACT
15-deoxy-delta 12,14-prostaglandin J2 (15d-PGJ2) is an anti-
inflammatory/anti-neoplastic prostaglandin that functions through
covalent binding to cysteine residues of various target proteins. We
previously showed that 15d-PGJ2 mediated anti-inflammatory
responses are dependent on the translational inhibition through its
interaction with eIF4A (Kim et al., 2007). Binding of 15d-PGJ2 to
eIF4A specifically blocks the interaction between eIF4G and eIF4A,
which leads to the formation of stress granules (SGs), which then
cluster mRNAs with inhibited translation. Here, we show that the
binding between 15d-PGJ2 and eIF4A specifically blocks the
interaction between the MIF4G domain of eIF4G and eIF4A. To
reveal the mechanism of this interaction, we used computational
simulation-based docking studies and identified that the carboxyl tail
of 15d-PGJ2 could stabilize the binding of 15d-PGJ2 to eIF4A
through arginine 295 of eIF4A, which is the first suggestion that the
15d-PGJ2 tail plays a physiological role. Interestingly, the putative
15d-PGJ2 binding site on eiF4A is conserved across many species,
suggesting a biological role. Our data propose that studying 15d-
PGJ2 and its targets may uncover new therapeutic approaches in
anti-inflammatory drug discovery.
KEY WORDS: 15d-PGJ2, eIF4A, Inflammation, Prostaglandins,
Stress granules, Translation
INTRODUCTION
15-deoxy-delta 12,14-prostaglandin J2 (15d-PGJ2) is an anti-
inflammatory and anti-neoplastic prostaglandin. Although 15d-
PGJ2 is known as an agonist of peroxisome proliferator-activated
receptor-gamma (PPARγ), which is a transcriptional modulator that
represses transcription of pro-inflammatory mRNAs, evidence
suggests that 15d-PGJ2 also can function independently of
PPARγ (Nosjean and Boutin, 2002). It has been reported that the
PPARγ-independent action of 15d-PGJ2 resulted from the covalent
modification of cysteine residues of target proteins. For example,
15d-PGJ2 blocks pro-inflammatory NF-κB signaling cascades
independently of PPARγ through direct interactions with signaling
molecules such IKK (IκB kinase) (Straus et al., 2000). Other
physiological activities of 15d-PGJ2, such as cytoprotection and
inhibition of cell proliferation, have also been reported to have
occurred through this direct binding property of 15d-PGJ2 (Pereira
et al., 2006). 15d-PGJ2 is a member of the cyclopentenone-type
prostaglandins (PGs). Cyclopentone-type PGs, unlike other classes
of PGs, contain an electrophilic α,β-unsaturated ketone moiety in
the cyclopentenone ring. This reactive center of the cyclopentenone
PGs can act as a Michael addition acceptor and react with
nucleophiles, such as the free thiol group of the glutathione and
cysteine residues in cellular proteins. These properties of 15d-PGJ2
could explain the biological activities of 15d-PGJ2 independent of
PPARγ (Shibata, 2015; Kondo et al., 2002).
Among the cellular proteins that are covalently modified by
15d-PGJ2, eIF4A is the only factor that directly modulates the
initiation of translation (Kim et al., 2007). eIF4A is the founding
member of the ‘DEAD-box’ family of ATP-dependent helicases
(Rogers et al., 2001; Oberer et al., 2005). It consists of two distinct
domains connected through a short linker, and both domains are
required for proper function of the helicase. The ATPase activity of
eIF4A is stimulated by eIF4G, and the helicase activity of eIF4A,
either alone or as part of the eIF4F complex, is stimulated by eIF4B
(Rozen et al., 1990; Schütz et al., 2008).
Recent studies focus on the function of eIF4A and its relation
to cancer and inflammation for the following reasons. First, it
was reported that PDCD4, a novel tumor suppressor protein,
interacts with eIF4A, which results in the inhibition of helicase
activity and translation (Yang et al., 2003), indicating that
blocking the cell-proliferative function of eIF4A is a critical step
to suppress tumorigenesis. Second, pateamine A (PatA), a potent
anti-proliferative and pro-apoptotic marine natural product, can
bind to and enhance the intrinsic enzymatic activities of eIF4A.
PatA inhibits the eIF4A-eIF4G association and promotes the
formation of a stable ternary complex between eIF4A and eIF4B
(Low et al., 2005). Finally, our previous report suggests that
15d-PGJ2 covalently binds to a cysteine residue (C264) in
eIF4A, resulting in the inhibition of translation initiation and
formation of stress granules (SGs) (Kim et al., 2007). Following
our previous results, here we report further characterization of the
interaction between 15d-PGJ2 and eIF4A. Also, we will showReceived 27 April 2018; Accepted 3 September 2018
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the effect of 15d-PGJ2 on various model organisms following
our findings on evolutionary conserved 15d-PGJ2 binding sites
of eIF4A across species.
RESULTS AND DISCUSSION
15d-PGJ2 binding to eIF4A specifically blocks the
interaction between the MIF4G domain of eIF4G and eIF4A
We previously reported that the direct interaction between 15d-
PGJ2 and eIF4A can specifically block eIF4A–eIF4G binding and
inhibit translation initiation (Kim et al., 2007). To further analyze
this interaction, we performed a series of immunoprecipitation
experiments using other eIF4GI interacting proteins. When we
immunoprecipitated FLAG-tagged eIF4A1, eIF4E or eIF3c, then
performed immunoblotting with eIF4G antibody, we identified that
the interactions of eIF4G with eIF4E (Fig. 1A, lanes 3 and 4) were
partially affected by 15d-PGJ2, while the association of eIF4G with
eIF3c was not affected (Fig. 1A, lanes 5 and 6). The interaction
between eIF4A1 and eIF4GI is blocked by 15d-PGJ2 as we
previously described (Fig. 1A, lanes 1 and 2) (Kim et al., 2007). We
also confirmed that the RNA-mediated interaction between eIF4A
and PABP is not inhibited by 15d-PGJ2 treatment, rather 15d-PGJ2
enhance the RNA-mediated interaction between eIF4A and PABP
(Fig. S1A). This data is consistent with our previous report that the
RNA-binding activity of eIF4A is increased when it binds to 15d-
PGJ2 (Kim et al., 2007). In addition, the interaction between eIF4A
and eIF4B is not affected by 15d-PGJ2 binding to eIF4A (Fig. S1B).
These data suggest that 15d-PGJ2 binding to eIF4A specifically
blocks the interaction between eIF4G and eIF4A while promoting
its binding to PABP.
It has been known that human eIF4G has two domains, MIF4G
(HEAT-1) and MA-3 (HEAT-2) for the interaction with eIF4A
(Oberer et al., 2005; Schütz et al., 2008; Imataka and Sonenberg,
1997; Lomakin et al., 2000; Craig et al., 1998; Marintchev et al.,
2009) (Fig. 1B). However, it is unknown whether eIF4A interacts
with two binding domains of eIF4G through the same surface or
different surfaces. To identify which eIF4A interaction domain of
eIF4GI is sensitive to 15d-PGJ2’s binding to eIF4A, we expressed
subdomains of GFP-tagged eIF4GI with FLAG-eIF4A then
performed an immunoprecipitation assay using anti-FLAG
antibody. The interaction between full-length GFP-eIF4GI and
FLAG-eIF4A is inhibited by 15d-PGJ2 treatment as expected
(Fig. S1C). The interaction between FLAG-eIF4A and GFP-
eIF4GI-MC, which contains both MIF4G and MA3 domain, was
significantly inhibited by 15d-PGJ2 (Fig. 1C). When the GFP-
eIF4GI-M, which contains only MIF4G domain, was expressed
with FLAG-eIF4A, their interaction was also interrupted by 15d-
PGJ2 treatment (Fig. 1D). However, the interaction between FLAG-
eIF4A and GFP-eIF4GI-C, which contains only MA3 domain, was
not affected by 15d-PGJ2 (Fig. 1E). We also tested the effect of 15d-
PGJ2 on the interaction between eIF4A and eIF4GII, a paralogue of
eIF4GI. However, we could not detect a strong interaction between
overexpressed GFP-eIF4GII and FLAG-eIF4A, nor the effect of 15d-
PGJ2 on this interaction (Fig. S1D). We also confirmed that the
interactions between eIF4A and the binding domains of eIF4GII are
not affected by 15d-PGJ2 (Fig. S1E–G). These data suggest that the
interaction between the MIG4G domain of eIF4GI, not eIF4GII and
eIF4A, is more sensitive to 15d-PGJ2 binding to eIF4A.
To further characterize whether 15d-PGJ2 blocks binding of
eIF4A to interactors other than eIF4G, we tested the effect of 15d-
PGJ2 on eIF4G homologues containing eIF4A binding domains or
on other eIF4A binding partners containing MIF4G or MA3
domains (Fig. 1B). The interactions of eIF4A with PAIP1 or with
DAP5, both of which contain regions similar to the MIF4G domain,
were significantly reduced by 15d-PGJ2 (Fig. 1F,G). The
interaction of PDCD4, an MA-3 domain containing protein, with
eIF4A was slightly affected by 15d-PGJ2 (Fig. 1H). It has been
reported that eIF4A interacts with the RNA binding protein RMB4,
which does not contain MIF4G or MA3 domains (Lin et al., 2007).
The interaction between RBM4 and eIF4A is not inhibited by 15d-
PGJ2, rather their interaction was slightly increased when 15d-PGJ2
was added to the binding reaction (Fig. 1I). All these data suggest
that 15d-PGJ2 binding to eIF4A specifically blocks the interaction
between MIF4G domain and eIF4A.
To further investigate the 15d-PGJ2 interacting residues within
eIF4A, we decided to use a computational approach to simulate the
interaction between 15d-PGJ2 and the structural model of human
eIF4A. Homology modeling, which is template-based modeling,
constructs an atomic-resolution model structure of the ‘target’
protein using its amino acid sequence and its homologous protein
structure (‘template’) obtained from experiments. Homology
modeling assumes that the protein structures are more conserved
than protein sequences. Practically, the proteins with sequence
similarities of more than 30% can be used as templates (Yang and
Honig, 2000; Yun, 2012). The method provides accurate models of
protein structures, which can be used for the study of protein-protein
and protein-ligand docking, of site-directed mutagenesis, and of
catalytic mechanism investigation. Docking simulation predicts the
orientation of the binding of small molecules (ligands and drug
candidates) to their target proteins and infers the affinity and activity
of the small molecules (Yuriev and Ramsland, 2013). Therefore, it
has played an important role in the rational design of drugs
(structure based drug screening). We take advantage of using
docking simulation since it samples the conformations of ligands in
the binding site of proteins and provides reliable binding modes
through assessing the conformations using a scoring function (Vieth
et al., 1998).
We used the model structure of 15d-PGJ2 based on a previous
study (Fig. 2A–B see Materials and Methods for details) (Pande and
Ramos, 2005). Then we built the model structure of human eIF4A-1
based on the crystal structure of MjDEAD from the
hyperthermophile Methanococccus jannaschii (PDB id; 1HV8)
(see the Materials and Methods). The sequence homology between
MjDEAD and eIF4A-1 was 33.8% and similarity was 54.4%. We
confirmed that nearly all motifs characterizing the DEAD-box
helicases in eIF4A were conserved in MjDEAD (Fig. S2A). When
we performed the docking simulation, we found that there are nine
plausible residues of eIF4A that might interact with 15d-PGJ2
(E257, D261, T262, C264, D265, R295, L400, D404, I406), which
are presented as Van der Waals contact surfaces (Fig. 2D and see the
Materials and Methods). It is already known that 15d-PGJ2 contains
a reactive α,β-unsaturated ketone in the cyclopentenone ring in
which an electrophilic carbon is susceptible for Michael addition
(Straus and Glass, 2001). Among those amino acid residues of
eIF4A that simulations predicted to interact with 15d-PGJ2, only
C264 is in proximity to the electrophilic carbon in the head region of
15d-PGJ2 (distance 3.8Å), which is a distance compatible with
covalent bonding, to undergo aMichael addition to eIF4A (Fig. 2D).
We also confirmed that C264 is located at the most solvent
accessible surface among all Cys residues of eIF4A (Fig. 2C),
further suggesting that C264 is the likely site of modification with
15d-PGJ2 as we previously reported (Kim et al., 2007).
By analyzing the docking simulation data of 15d-PGJ2-eIF4A,
we also found that R295 residue of eIF4A might interact strongly
with 15d-PGJ2 and makes the hydrogen bond (Fig. 2D). Thus, we
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suggest that the hydrogen bond between the tail of 15d-PGJ2 and
R295 residue of eIF4A might be responsible in stabilizing the
flexible alpha-chain of 15d-PGJ2 and in aiding the chain to dock
easily with eIF4A. This simulation data suggests to us that R295 can
be an important target residue as 15d-PGJ2 recognizes eIF4A and
binds to it.
Fig. 1. See next page for legend.
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Next, we tested whether the relationship between C264 and R295
is conserved through evolution. It is known that the residues that
play structurally or functionally important roles within proteins are
evolutionary conserved and have high covariance values (Lockless
and Ranganathan, 1999; Süel et al., 2003). To investigate
the functional importance of C264 and R295, we calculated the
covariance value for all residue pairs using homologues of human
eIF4A1 (Fig. S2C) (see the Materials and Methods). The histogram
of cumulative counts shows that most pairs of residues have no
strong correlations, however the covariance value of the C264-R295
pair is within the top 10% in eIF4a (Fig. S2B). This result suggests
that both C264 and R295 participate together in an important
biological function that may include binding to 15d-PGJ2.
To experimentally confirm the structural relevance of the
interaction between C264/R295 of eIF4A and 15d-PGJ2, we
generated a C264S and R295Amutant of eIF4A. Binding of R295A
mutant with 15d-PGJ2 is not reduced compared with wild-type
(WT) eIF4A, rather it increased slightly (Fig. 3A, lanes 1 and 3).
However, the binding of 15d-PGJ2 with C264S/R295A double
mutant of eIF4A is significantly reduced compared with C264S
mutant of eIF4A (Fig. 3A, lane 4), suggesting that R295 region has
an additive function in stabilizing the interaction between 15d-PGJ2
and eIF4A.
Next, we tested the effect of R295A mutation on the interactions
between eIF4A and eIF4GI, which is inhibited by the binding of
15d-PGJ2 to eIF4A. The binding of C264S mutant eIF4A to eIF4GI
was comparable to WT eIF4A (lane 3 of Fig. 3B). However, the
inhibitory effect of 15d-PGJ2 was dramatically reduced by that
mutation (lanes 3 and 4 of Fig. 3B). The binding of R295A mutant
eIF4A to eIF4GI was comparable to WT eIF4A (lane 5 of Fig. 3B),
and the inhibitory effect of 15d-PGJ2 was also similar to WT (lanes
5 and 6 of Fig. 3B). When we tested the interaction between C264S/
R295A double mutant eIF4A and eIF4GI, we found a slight
decrease in the interaction (lane 7 of Fig. 3B). This interaction was
not inhibited by 15d-PGJ2 treatment, suggesting that 15d-PGJ2
cannot bind to double mutant eIF4A and thus cannot block its
interaction with eIF4G (lanes 7 and 8 of Fig. 3B). All these data
suggest that R295 of eIF4A is an important target residue for
15d-PGJ2, which can regulate the interactions between eIF4A and
eIF4GI.
To test the role of C264 and R295 residues of eIF4A in
15d-PGJ2-mediated physiological responses, we measured the
numbers of SGs in transfected cells with different eIF4A constructs.
We previously identified that the anti-inflammatory effect of 15d-
PGJ2 partly results from inhibition of translational initiation (Kim
et al., 2007) and SG formation are a good indicator of translational
initiation blockage. We decided to compare the effect of sodium
arsenite (SA) on SG formation to that of 15d-PGJ2 since the SG-
inducing-mechanisms of these two agents are distinct (Kim et al.,
2007). SA induces SG formation via phosphorylation of eIF2α,
which inhibits efficient GDP-GTP exchange, leading to a decrease
in levels of translationally competent eIF2/GTP/tRNAiMet ternary
complex, and inhibits translation initiation. In contrast to SA,
15d-PGJ2-dependent SG formation is independent of eIF2α
phosphorylation. Rather it targets eIF4A and inhibits the
interaction between eIF4A-eIF4G, leading to inhibition of
translation initiation (Panas et al., 2016).
We found that SA-induced SG formation is not affected either by
WT or double-mutant eIF4A overexpression (Fig. 3C), indicating
that SA-dependent – in other words – eIF2α-dependent SG
formation is not affected by any forms of eIF4A overexpression.
However, when the WT eIF4A was overexpressed, it could reduce
the formation of SGs induced by 15d-PGJ2 up to 20% (lane 2 of
Fig. 3D). When the mutant forms of eIF4As that do not bind to 15d-
PGJ2 were overexpressed, 15d-PGJ2-dependent SG formation was
reduced by up to 90% (Fig. 3D). These data suggest that 15d-PGJ2-
dependent SG formation is highly dependent on its binding to the
C264 and R295 residues of eIF4A.
C264 of eIF4A is highly conserved from worm to human
eIF4A and mechanisms of translation initiation are conserved across
many species. If 15d2-PGJ2 regulation of eIF4A is important across
species then its binding sites on eIF4A should be conserved. To
define the evolutionary importance of these two amino acids in
eIF4A, we compared the 15d-PGJ2 binding region of eIF4A among
various species from budding yeast to human (Fig. S2C). In most
species, C264 of eIF4A is highly conserved, however, in budding
yeast Saccharomyces cerevisiae, C264 is converted into tryptophan
(Fig. S2C). InDrosophilamelanogaster andCaenorhabditis elegans,
R295 is converted into histidine and asparagine, respectively
(Fig. S2C). Thus, we suggest that C264 and R295 of eIF4A are
relatively conserved through various species due to the 15d-PGJ2
actions in inflammation, partly through translational blockage.
We next decided to examine the effect of 15d-PJ2 on various
species showing the different amino acid pairs in the eIF4A region.
Fig. 1. 15d-PGJ2 blocks the interaction between the MIF4G domain
of eIF4G with eIF4A. (A) 293T cells were transfected with FLAG-eIF4A1
(lanes 1 and 2), FLAG-eIF4E (lanes 3 and 4), or FLAG-eIF3c (lanes 5 and
6). Cells were lysed then treated with EtOH or 10 µM of 15d-PGJ2 at 30°C
for 1 h. Immunoprecipitation was performed using anti-FLAG antibody then
western-blot analysis was performed with anti-FLAG and eIF4GI antibodies.
The quantification of the relative band intensity was performed using ImageJ
(see the Materials and Methods). Thus, the numbers described below the
band indicates the relative percentage of band intensity compared to the
neighboring bands. If the intensity of the neighboring bands is exactly same,
the values will be 50:50. The same quantification methods are used in all
figures unless otherwise specified. (B) eIF4A binding domain structures of
eIF4GI homologues were illustrated based on the Pfam graphical view of
domain structure (http://pfam.sanger.ac.uk). MIF4G domain homologues
were marked as grey, MA3 domain homologues as black. (C) 293T cells
were co-transfected with GFP-eIF4GI-MC and FLAG-eIF4A1. Cells were
lysed then treated with EtOH or 10 µM of 15d-PGJ2 at 30°C for 1 h.
Immunoprecipitation was performed as described above then western-blot
analysis was performed with anti-FLAG and anti-GFP antibodies. (D) 293T
cells were co-transfected with GFP-eIF4GI-M and FLAG-eIF4A1. Cells
were lysed then treated with EtOH or 10 µM of 15d-PGJ2 at 30°C for 1 h.
Immunoprecipitation was performed as described above then western-blot
analysis was performed with anti-FLAG and anti-GFP antibodies. (E) 293T
cells were co-transfected with GFP-eIF4GI-C and FLAG-eIF4A1. Cells were
lysed then treated with EtOH or 10 µM of 15d-PGJ2 at 30°C for 1 h.
Immunoprecipitation was performed as described above then western-blot
analysis was performed with anti-FLAG and anti-GFP antibodies. (F) 293T
cells were co-transfected with GFP-PAIP1 and FLAG-eIF4A1. Cells were
lysed then treated with EtOH or 10 µM of 15d-PGJ2 at 30°C for 1 h.
Immunoprecipitation was performed with an anti-FLAG antibody. Western-
blot analysis was performed with anti-FLAG and anti-GFP antibodies.
(G) 293T cells were transfected with FLAG-eIF4A1. Cells were lysed then
treated with EtOH or 10 µM of 15d-PGJ2 at 30°C for 1 h.
Immunoprecipitation was performed as described above then western-blot
analysis was performed with anti-FLAG and anti-DAP5 antibodies. (H) 293T
cells were co-transfected with HA-PDCD4 and FLAG-eIF4A1. Cells were
lysed then treated with EtOH or 10 µM of 15d-PGJ2 at 30°C for 1 h.
Immunoprecipitation was performed as described above then western-blot
analysis was performed with anti-FLAG and anti-HA antibodies. (I) 293T
cells were co-transfected with GFP-RBM4 and FLAG-eIF4A1. Cells were
lysed then treated with EtOH or 10 µM of 15d-PGJ2 at 30°C for 1 h.
Immunoprecipitation was performed as described above then western-blot
analysis was performed with anti-FLAG and anti-GFP antibodies.
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To test the possible action of 15d-PGJ2 on translational blockages
through eIF4A among various species, we chose several species and
performed a series of experiments. First, we treated zebrafish
embryos with 15d-PGJ2 at an early stage (4 hpf, hours post
fertilization) and found that it resulted in gastrulation defects. We
introduced two molecular markers, chd, as an involuting dorsal
Fig. 2. Carboxyl tail of 15d-PGJ2 interacts with R295 of eIF4A in docking simulation. (A) 2D structure of 15d-PGJ2. Image is from a previous paper
(Diers et al., 2010). (B) 3D structure of 15d-PGJ2. The head region of 15d-PGJ2 contains the reactive α,β-unsaturated ketone structure in red. The carboxyl
terminal of tail region in orange. (C) Homology model of human eIF4A-1 based on the crystal structure of MjDEAD (PDB ID: 1HV8). The Cys residues of
eIF4A are marked. C264 and R295 are solvent accessible residues and other cysteines (C66, C131, C134) are buried residues. Solvent accessible residues
and the buried residues are colored in blue and yellow, respectively. (D) The result of docking simulation between eIF4A and 15d-PGJ2. The ligand binding
site of eIF4A is highlighted inside the box. The hydrogen bonds between R295 of eIF4A and carboxyl tail of 15d-PGJ2 are presented as a dotted red line.
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Fig. 3. See next page for legend.
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mesoderm marker and myod, as an adaxial and somite marker
(Fig. 4A, right panels). In addition, zebrafish embryos treated
with 15d-PGJ2 at a later stage (10 hpf) showed a severe defect in
spinal cord development at 28 hpf (Fig. 4A, red dashed lines in
bottom panels).
Second, to understand the function of eIF4A in 15d-PGJ2-
mediated translational modulation, we chose Xenopus embryos to
genetically manipulate the expression of eIF4A and its mutant
forms. We found that Xenopus embryos also showed developmental
defects when treated with 15d-PGJ2 (Fig. 4B).When 15d-PGJ2 was
administered at a later developmental stage in Xenopus, most of the
animals showed growth retardation, mild eye loss or severe eye loss
(Fig. 4C, bottom panels and Fig. S4A) compared with mock-treated
animals, or animals treated with a control prostaglandin (PGE2) or
GW9662, potent PPAR-γ antagonist. Interestingly, developmental
defects induced by 15d-PGJ2 were rescued by eIF4A mRNA
injection (Fig. 4D). Inhibition of developmental defects by eIF4A
mRNA injection might be a result of buffering 15d-PGJ2 with
overexpressed eIF4A (Fig. S4B). In addition, C264S mutant eIF4A
mRNA injection almost completely rescued the developmental
defect induced by 15d-PGJ2, suggesting that the binding motif
of 15d-PGJ2 in eIF4A is critical for this developmental defect
(Fig. 4D).
Third, we moved to test the effect of 15d-PGJ2 in invertebrate
models. The eIF4A of fruit fly contains C264/H295 (Fig. S2C). We
found that Spodoptera frugiperda-derived Sf9 cells form SG-like
structures by SA and 15d-PGJ2 using antibodies against eIF4A and
RNA binding protein, HuR (Fig. 4E, yellow arrows on the right
panel). By searching the sequencing database Blast, we found that
the 15d-PGJ2 binding sites of eIF4A in S. frugiperda are conserved
as C264/R295 form (Fig. S4C). To confirm the effect on the
cap-dependent translation of SF9 cells by these chemicals, we
transfected dual luciferase mRNA in Sf9 cell line then treated them
with either SA or 15d-PGJ2. Interestingly, we found a strong
correlation between luciferase assay and immunocytochemical data
(Fig. 4F), indicating that 15d-PGJ2 can affect cap-dependent
translation in insect cells. It has been reported that metazoan SG
assembly is mediated by P-eIF2α-dependent and -independent
mechanisms (Farny et al., 2009), which is consistent with our data
(Fig. 4E,F). The phosphorylation of eIF2α induces stress signals in
Sf9 cells (Aarti et al., 2010), which is also consistent with our data
(Fig. 4E,F). All these data and reports suggest that 15d-PGJ2 can
induce SG formation resulting in inhibited cap-dependent
translation in invertebrate cells that contain conserved eIF4A
amino acid residues for binding to 15d-PGJ2.
CONCLUSION
Here we showed that the specific effect of 15d-PGJ2 on eIF4A is
dependent on conservation of C264 and amino acid residues in 295
position. First we showed that the binding of 15d-PGJ2 to eIF4A
mostly blocks the interaction between the MIF4G domain of eIF4G
and eIF4A. We showed that the interactions between eIF4E–eIF4G,
eIF3–eIF4G, eIF4G–PABP and eIF4A–eIF4B were not affected by
15d-PGJ2 treatments (Fig. 1A; Fig. S1A–B). It is known that eIF4G
contains two eIF4A binding motifs, MIF4G and MA3 domain.
Using a domain mapping strategy, we showed that the MIF4G
domain is responsible for the inhibitory effect on the interactions
between eIF4A and eIF4GI by 15d-PGJ2 (Fig. 1C–E; Fig. S1C–G).
We also successfully showed that binding of 15d-PGJ2 to eIF4A
inhibits the interaction betweenMIF4G domain and eIF4A by using
various eIF4G homologues and eIF4A binding partners (Fig. 1F–I).
Using a docking study, we identified that C264 of eIF4A can be
accessible to 15d-PGJ2 (Fig. 2C) and found a clue that the tail of
15d-PGJ2 may be located very close to R295 of eIF4A (Fig. 2C).
Although it is known that thiol modification of 15d-PGJ2 is enough
for direct binding to its targets, we suggest that the tail of 15d-PGJ2
can stabilize or initiate the binding to targets. We next confirmed
the predictions of our computer docking simulation with
experiments. Our data suggest that R295 of eIF4A plays a
critical role to stabilize the binding of 15d-PGJ2 and eIF4A
(Fig. 3). To confirm that the conservation of C264/R295 plays an
important role in translational regulation (Fig. S2B), we treated a
variety of species with 15d-PGJ2 (Fig. S2C). We found
interesting relations between C264/R295 conservation and
15d-PGJ2-mediated cell growth inhibition, translational
inhibition, and/or SG formation (Fig. 4; Fig. S4). In summary,
our study shows that 15d-PGJ2 specifically binds to C264/R295
residues of eIF4A and these binding properties are related to 15d-
PGJ2-mediated translational inhibition.
Powerful computational simulation-based docking studies are
widely used to design and modify drugs. Using this technique, we
could predict that the carboxyl tail of 15d-PGJ2 binds close to the
R295 of eIF4A. As we predicted, previous reports by other groups
also suggested that the carboxyl group of 15d-PGJ2 makes strong
hydrogen-bonding interactions through lysine or arginine of target
proteins (Pande and Ramos, 2005). Moreover, the carboxyl of PG-
like fatty acids has been experimentally considered as an important
determinant for molecular recognition with their natural receptors
(Nolte et al., 1998; Xu et al., 1999). A previous study of eIF4A
showed that D265 and D296 play a key role in its binding to eIF4G
(Oberer et al., 2005). The crystal structure of the yeast eIF4A-eIF4G
complex revealed that eIF4G-S612 makes a hydrogen bond with
eIF4A-T252 [corresponding to C264 in human eIF4A (Oberer et al.,
2005)] and eIF4G-E628 and D595 form a salt bridge with eIF4A-
K284 [corresponding to D296 in human eIF4A (Oberer et al., 2005;
Schütz et al., 2008)]. Whether the function of the 15d-PGJ2 tail is to
affect stabilization or initiation of binding to eIF4A before covalent
modification is not known, our experimental data shows that R295
of eIF4A is important for the binding of 15d-PGJ2 (Fig. 3). Since
15d-PGJ2 has multiple targets (Pande and Ramos, 2005), a docking
study and experimental studies with these targets will be required to
Fig. 3. Binding of 15d-PGJ2 to arginine 295 of eIF4A is important for
interaction with eIF4G and stress granule (SG) formation. (A) 293T cells
were transfected with the WT (lane 1) or mutant (lanes 2–4) FLAG-eIF4A1s.
Biotin pull-down assay was performed using biotin-15d-PGJ2 as described
in the Materials and Methods. Western-blot analysis was performed with
anti-FLAG and anti-eIF4GI antibodies. The bands of each lane are
quantified using ImageJ as described in the Materials and Methods. Then
the relative ratio of bound/input is calculated and visualized as a graph
below the band. (B) 293T cells were transfected with the WT (lanes 1 and 2)
or mutant (lanes 3–8) FLAG-eIF4A1. Immunoprecipitation was performed in
the absence or presence of 15d-PGJ2 as described in the Materials and
Methods. Western-blot analysis was performed with anti-FLAG, anti-DAP5,
anti-eIF4GI antibodies. The bands of each lane were quantified using
ImageJ as described in the Materials and Methods. Then the relative ratio of
bound/input is calculated and visualized as graph below the band. (C,D)
HeLa cells were grown on cover slips and transfected with a FLAG vector,
WT eIF4A, or mutant eIF4As (C264S, R295A and C264S/R295A). After
48 h of incubation, cells were treated with the 400 µM of SA (C) or 100 µM of
15d-PGJ2 (D) for 30 min. Cells were fixed and immunocytochemical
analyses were performed with anti-FLAG and anti-eIF3b antibodies. SGs
were counted among FLAG-eIF4As transfected cells. Each circle was
normalized with vector transfectant. (C′,C″,D′,D″) Samples counted in
panels C and D were visualized. FLAG-eIF4As are green, eIF3B is red.
The nuclei are shown in blue by Hoechst staining. SGs are marked as
yellow arrows. Scale bars: 30 µm.
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confirm the role of the 15d-PGJ2 tail region in interactions with
other targets.
What is the implication of these molecular interactions on
translational regulation? There are several interesting perspectives
provided by the molecular details from our study. First, our data
suggest that the binding of 15d-PGJ2 to eIF4A shows highly
specific effects on cellular physiology. For example, it only affects
the translational initiation step thus inducing SG formation. The
binding of 15d-PGJ2 to eIF4A only blocks the interactions between
eIF4G–eIF4A, not eIF4E–eIF4G, eIF3–eIF4G, or eIF4A–eIF4B
(Fig. 1A; Fig. S1B). Rather, 15d-PGJ2 binding to eIF4A increases
the interactions between eIF4A and RNA (Kim et al., 2007), thus
resulting in increases in the interactions between eIF4A and PABP
(Fig. S1A), which accounts for the RNA-mediated interaction.
Fig. 4. See next page for legend.
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Interestingly, the helicase activity of eIF4A was not altered by
15d-PGJ2 treatment (Fig. S3), indicating that the binding of
15d-PGJ2 to eIF4A specifically blocks its interactions with eIF4G.
It has been identified that MIF4G domain (also called the
HEAT-1 domain) is mainly responsible for the binding of eIF4G to
the eIF4AC-terminus (237-406) (Marintchev et al., 2009). We also
found that 15d-PGJ2 treatment only blocks the interactions between
eIF4A and eIF4GI, PAIP1, and DAP5 but not the interactions
between eIF4A-PDCD4 and eIF4A-eIF4GII. PDCD4 is a newly
characterized tumor suppressor gene and functions by isolating
eIF4A from eIF4F complexes (Yang et al., 2003). If 15d-PGJ2 only
blocks translation through the MIF4G domain but not the function
of PDCD4, the anti-proliferative effect of 15d-PGJ2 and PDCD4
may be cumulative within cells. The interactions between eIF4A–
eIF4GII was relatively weak and not affected by 15d-PGJ2 treatment
(Fig. S1C–G). eIF4GI and eIF4GII have differing functions, as
reported by other groups (Svitkin et al., 1999), however, we are
unsure why 15dPGJ2 may not bind to eIF4GII. Further study is
required to find the molecular details of this phenomenon.
Cyclopentenone prostaglandins are produced at the late stage of
inflammatory responses to stop the positive feedback loop and
prevent sustained inflammation (Straus et al., 2000; Straus and Glass,
2001). Previously, we suggested that the anti-inflammatory action of
15d-PGJ2 partially resulted from translational inhibition. We also
suggested that eIF4A is a possible candidate for that function of 15d-
PGJ2 (Kim et al., 2007). If this were the case, C264 of eIF4Awould
be critical for 15d-PGJ2 actions. Evolutionary conservation of the
C264 of eIF4A among mammals and many multicellular organisms
motivated us to test this possibility (Fig. S2C). From mammals to
insects, 15d-PGJ2 inhibited cap-dependent translation (Fig. 4A),
induced SG-like structures (Fig. 4E), or disrupted development
(Fig. 4A–D). We cannot conclude that all these phenomena result
from 15d-PGJ2 effects on eIF4A; however, 15d-PGJ2 treatment of
Xenopus embryos with eIF4A mRNA could prevent developmental
defects induced by 15d-PGJ2 (Fig. 4D). We also confirmed that a
C264S mutant eIF4A, which is resistant to 15dPGJ2, can rescue the
developmental delay better than WT eIF4A, suggesting that the
binding specificity of 15d-PGJ2 to C264 of eIF4A is critical for
developmental delays in Xenopus embryo. Thus, overexpression of
eIF4A can rescue the developmental defects induced by 15d-PGJ2 at
least in Xenopus embryos.
15d-PGJ2 is synthesized through the dehydration of PGD2.
PGD2 synthesis requires PGD2 synthases: HPGDS (entrezID:
27306) and LPGDS (entrezID: 5730) (Scher and Pillinger, 2005).
The existence of PGD2 synthases in the genome of species could be
a possible criteria of 15d-PGJ2 production in that species. To test
this possibility, we searched for the orthologues of human PGDS
using InParanoid (Fig. S5). The orthologues of PGDS are found in
mouse, Xenopus and Drosophila in which C264 is conserved. In
those species, 15d-PGJ2 can induce SG-like structures (Fig. 4E),
disrupt development (Fig. 3A–D), or inhibit translation (Fig. 4F). In
zebrafish, however, orthologues of PGDS were not found though
the treatment of 15d-PGJ2 induces developmental defects (Fig. 4A).
This suggests the possible existence of different enzymes producing
PGD2 in zebrafish. Although there is the exceptional case, as with
zebrafish, the effect of 15d-PGJ2 seems to be correlated with the
existence of PGDS in the genome of the species.
Our findings can provide the strategy to design more efficient
drugs. For example, covalent modification of HIV Tat protein by
15d-PG2 can be applied to design anti-viral drugs. Since 15d-PGJ2
has specific cellular target proteins, finding targets and designing
more efficient structures will be helpful for medical applications
such as Ischemia reperfusion (Blanco et al., 2005; DeGracia et al.,
2006; Kayali et al., 2005; Murry et al., 1986; Kloner and Rezkalla,
2006; McDunn and Cobb, 2005; Lin et al., 2006). Together with
small molecules showing anti-cancer effects such as Pateamine A
and 4EGI-1 (Korneeva et al., 2001), we suggest that targeting the
process of translational initiation could be a reasonable strategy to
improve anti-cancer and anti-inflammatory treatments.
MATERIALS AND METHODS
Statement on animal research
Research using animals (Xenopus) has made, and continues to make, a vital
contribution to the understanding, treatment and cure of major human and
animal health problems, including cancer, heart disease, polio, diabetes and
neurological diseases and disorders.While newmethods have enabled scientists
and medical researchers to reduce the number of studies involving animals,
some work must continue for further fundamental advances to be made.
The POSTECH only uses animals in research where there are no
alternatives. In fact, the law demands that where a non-animal approach
exists, it should be used. The principles of reduction, refinement and
replacement of animals in research (the ‘3Rs’) underpin all related work
carried out at the University, ensuring that the number of animals used is
minimized and that procedures, care routines and husbandry are refined and
regularly reviewed to maximize welfare.
Plasmid construction
Plasmid information is described elsewhere (Kim et al., 2007, 2005). Site-
directed mutagenesis was performed byDpnI selection method using proper
primers. All plasmids are sequenced to confirm the mutagenesis.
Antibodies and chemicals
Antibody against FLAG was purchased from Sigma-Aldrich, GFP and HA
from Santa Cruz Biotechnology. Antibody against eIF4GI was prepared in
our laboratory (Kim et al., 2005). Chemicals 15d-PGJ2, biotinylated 15d-
PGJ2 and PGE2 were purchased from Cayman Chemical. Sodium arsenite
Fig. 4. The effect of 15d-PGJ2 on various species. (A) Zebrafish embryos
were mock treated or treated with 10 µM of 15d-PGJ2 at two different
developmental stages (4 hpf or 10 hpf) and examined at later stages.
15d-PGJ2 treatment caused a gastrulation defect at an early stage (6ss, 6
somite stage) and spinal cord defects at a later stage (28 hpf), respectively.
Early effects of 15d-PGJ2 were confirmed by using two molecular markers:
chd (85% epiboly stage; L, lateral view; D, dorsal view) and myod (8ss,
dorsal view). (B) Xenopus embryos were mock treated or treated with 20 µM
of 15d-PGJ2 from stage 4 and cultured until gastrula stage (stage 11). Note
that embryos treated with 15d-PGJ2 were developmentally arrested at early
blastula stage. (C) Xenopus embryos were mock treated or treated with
20 µM of 15d-PGJ2, PGE2, or GW9662 after the onset of gastrulation (stage
11). Phenotypes were counted at stage 35. Among 52 embryos treated
with 15d-PGJ2, 18 were growth retarded as shown by reduced trunk
pigmentation and delayed eye formation, 20 showed mild eye defects, and
14 showed loss of eye and defects in dorsal axis. (D) Xenopus embryos
were injected with β-galactosidase mRNA, eIF4A mRNA, or eIF4A C264S
mutant mRNA at stage 2 and mock treated or treated with 20 µM of 15d-
PGJ2 from 16-cell or 32-cell stages. Embryos were cultured until stage 11
and fixed. β-galactosidase mRNA injection or mock treatment was
performed for the negative control. eIF4A injection rescued developmental
arrest induced by 15d-PGJ2 administration (9/17, 53%), as well as did eIF4A
C264S injections (14/15. 93%). (E) Sf9 cells were grown on cover slips and
mock-treated (top panel), treated with 400 µM of SA (middle panel), or
50 µM of 15d-PGJ2 (bottom panel). Immunocytochemical analyses were
performed with anti-eIF4A1 (green) and anti-HuR (red) antibodies.
The nuclei are shown in blue by Hoechst staining. (F) Sf9 cells were
co-transfected with monocistronic mRNAs containing renilla luciferase with
cap-structure and firefly luciferase with CrPV IRES. After 4 h of trasnfection,
cells were mock treated (lane 1), treated with 400 µM of SA (lane 2), or
100 µM of 15d-PGJ2 (lane 3) for 1 h. Luciferase assay was performed and
relative luciferase activity was shown. Rluc/Fluc ratio means eIF4A
dependent translation. Scale bars: 30 µm.
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was purchased from Sigma-Aldrich. Immobilized streptavidin agarose was
purchased from Pierce.
Quantification of western blot analysis
We quantified the density of bands using ImageJ (http://rsb.info.nih.gov/ij/
index.html) software. We created digital images of gels using a digital
scanner then followed the protocol for gel analysis menu in ImageJ
(Schneider et al., 2012). In short, we converted gel images to 8-bit images
then chose the rectangular selections tool to draw a rectangle around the first
each lane. After drawing the rectangles, we plotted lanes using the plot lanes
menu then chose the peak using the straight line selection tool. When all the
peaks were highlighted, we labeled peaks to express the percentage of each
peak compared to the total size of all the highlighted peaks. The
quantification method used above is described elsewhere (Tan and Ng,
2008; Gassmann et al., 2009).
Cell cultures and transient transfection
HeLa cells and 293T cells were grown as described elsewhere (Kim et al.,
2005).
Pull-down with streptavidin and immunoprecipitation
Biotin pull-down and immunoprecipitation experiments were performed as
described elsewhere (Kim et al., 2007). In short, 293T cells transfected with
DNAwere lysed using the NP-40 lysis buffer. The lysates were clarified by
centrifugation at 14,000 g for 15 min. Anti-FLAG monoclonal antibody
(4 μg) was incubated with 20 μl of protein G agarose for 1 h in 1 ml NP-40
lysis buffer at 4°C. Lysates were pre-cleared with 10 μl of protein G agarose
at 4°C for 30 min. After pre-clearing, cell lysates were treated with 50 μMof
EtOH, PGE2, or 15d-PGJ2 at 30°C for 1 h, followed by centrifugation.
Then protein G agarose-conjugated antibodies were incubated with the pre-
cleared lysates at 4°C for 1 h. Precipitates werewashed three times with lysis
buffer and analyzed by SDS–PAGE.
Fluorescence microscopy
The immunocytochemical analyses of proteins were performed as described
elsewhere (Kim et al., 2005). In short, after transfection of DNA, cells were
grown on coverslips coated with 0.2% gelatin for 48 h and then washed three
times with phosphate-buffered saline (PBS). The cells were fixed with 3.5%
(wt/vol) paraformaldehyde (Sigma-Aldrich) at room temperature (RT) for
12 min. After being washed three times with PBS, the cells were
permeabilized with 0.1% Triton X-100 at RT for 2 min and then washed
three times with PBS. The samples were soaked in blocking solution (PBS
containing 1% bovine serum albumin) for 30 min at RT and then incubated
with primary antibodies for 1 h at RT. After being washed with PBS,
the samples were treated with Hoechst 33258 for 2 min at RT and washed
againwithPBS three times. Sampleswere treatedwith rhodamine tetramethyl
isocyanate-conjugated and/or fluorescein isothiocyanate-conjugated
secondary antibodies (Jackson ImmunoResearch) for 1 h at RT. Finally, the
coverslipswerewashed three timeswithPBS, placed on a glass slide, and then
sealed with transparent nail polish. The fluorescent images were captured
with a cooled charge-coupled device camera and a Zeiss (Jena, Germany)
Axioplan microscope. Data were processed using ImageJ software.
Luciferase assay
Luciferase assays were performed as described elsewhere (Kim et al., 2005).
In short, monocistronic mRNAs containing renilla luciferase with cap-
structure, and firefly luciferase with CrPV IRES were transfected together
into Sf9 cells by lipopectamine. After 12 h of transfection, SA or 15d-PGJ2
was added to cells for 1 h then luciferase assays were performed with a dual
luciferase assay kit (Promega) per the manufacturer’s instructions. Renilla
luciferase activity values were normalized by firefly luciferase activity
values that reflect transfection efficiency and general cellular activities.
Insect cell cultures
BTI-TN-5B1-4 cells (High Five; Invitrogen) were maintained and transfected
as described elsewhere (Farrell and Iatrou, 2004). Monocistronic Rluc and
Fluc plasmids are described elsewhere (Kim et al., 2007).
Xenopus embryo manipulation
Xenopus eggs were obtained and fertilized as described elsewhere (Kim and
Han, 2007). Nieuwkoop and Faber stages were considered for the Xenopus
developmental staging (Nieuwkoop and Faber, 1956). In vitro synthesized
eIF4A mRNAwas introduced into the Xenopus embryos by microinjection
using Nanolitre injector (WPI). Embryos were cultured in 0.33X-modified
ringer (MR) and treated with 20 µM of 15d-PGJ2 or GW9662 from the
indicated stages.
Zebrafish experiment
Zebrafish were maintained at 28.5°C in a 14 h light/10 h dark cycle.
Embryonic stages were determined by the hours post fertilization (hpf) and
microscopic observation. Zebrafish embryos were treated with 10 µM of
15d-PGJ2 at two different developmental stages, 4 hpf (before gastrulation)
and 10 hpf (after gastrulation), respectively. Wholemount in situ
hybridization was performed as previously described (Jung et al., 2010).
Homology modeling and docking
Crystal structure (1HV8) of MjDEAD extracted from the hyperthermophile
M. jannaschii is used as a template to build the homology model of the
human eIF4A1 (Oberer et al., 2005) using Modeller8v (Sali and Blundell,
1994). MjDEAD and human eIF4A1 share high sequence identity and
similarity, 33.8% and 54.4%, respectively. The sequence alignment between
human eIF4A-1 and MjDEAD was performed using ClustalW (Chenna
et al., 2003) and the alignment score was calculated from EMBOSS-align
(Rice et al., 2000). Cα RMSD was calculated using MOE (Chemical
Computing Group, 2008). The model structure of eIF4A-1 was energy-
minimized using AMBER9 (Case et al., 2006). Since CYS is oxidized in the
experimental environment, CYM potential parameters were used for CYS in
the energy-minimized. We docked 15d-PGJ2 into the human eIF4A-1
model structure using eHiTS (Kerwin, 2005). eHiTS considers the
flexibility of the ligand and generates all possible ligand conformations,
which has proven to be effective for modeling a ligand docking model.
Before docking, 15d-PGJ2 was energy-minimized by ab initio quantum
chemical calculation using Gaussian program (Frisch et al., 2004). The
energy-minimized 15d-PGJ2 was docked to the eIF4A-1 model.
Calculation of covariance
We found 500 homologues of the human eIF4A-1 using wu-BLAST and
filtered out 197 sequences whose length is smaller than 0.7 times or larger
than 1.4 times of human eIF4A sequence and whose identity is greater than
90%. We removed all columns with gaps more than 50%. Finally, 303
selected sequences were aligned with human eIF4A sequences and the
co-variance was calculated using ELS (Dekker et al., 2004; Fodor and
Aldrich, 2004).
Conserved C-R pair in vertebrate orthologues of human eIF4A-1
We aligned 11 orthologues of human eIF4A-1 from InParanoid, Eukaryotic
Ortholog Groups (Remm et al., 2001), using ClustalW.
Searching orthologues of PGDS
We search InParanoid, the Eukaryotic Ortholog Groups, for the orthologues
of human PGDS (Remm et al., 2001), excluding inparalogues scoring
below 0.05.
Helicase assay
We performed in vitro helicase assay using 32P-labeld oligonucleotides as
described elsewhere (Kim and Seo, 2009). The oligonucleotide sequences we
used are described below. R-28-5’; 28mer: aaaacaaaacaaaauagcaccguaaagc
and R-13; 13mer: gcuuuacggugcu.
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